Gene | Score gda | Association Type | Type | Original DB | Sentence supporting the association | PMID | PMID Year | ||||
---|---|---|---|---|---|---|---|---|---|---|---|
|
0.370 | Biomarker | disease | BEFREE | Essential role for EGFR tyrosine kinase and ER stress in myocardial infarction in type 2 diabetes. | 29288332 | 2018 | ||||
|
0.370 | Biomarker | disease | BEFREE | Serum Soluble Epidermal Growth Factor Receptor Level Increase in Patients Newly Diagnosed with Type 2 Diabetes Mellitus. | 29885103 | 2018 | ||||
|
0.370 | Biomarker | disease | BEFREE | Inhibition of Epidermal Growth Factor Receptor Activation Is Associated With Improved Diabetic Nephropathy and Insulin Resistance in Type 2 Diabetes. | 29959129 | 2018 | ||||
|
0.370 | Biomarker | disease | BEFREE | ADA = American Diabetes Association CRP = C-reactive protein DD = definite diabetes FPG = fasting plasma glucose HbA1c = glycosylated hemoglobin MENA = Middle-East North Africa ND = no diabetes PD = probable diabetes RD = at risk of diabetes T2D = type 2 diabetes mellitus TSH = thyroid-stimulating hormone. | 28683240 | 2017 | ||||
|
0.370 | Biomarker | disease | BEFREE | Consequently, the application of metformin for T2D NSCLC patients receiving chemo or EGFR targeted therapy should be considered with caution. | 28391030 | 2017 | ||||
|
0.370 | Biomarker | disease | BEFREE | In this study, we found that metformin (Met), which is widely used for the treatment of type 2 diabetes (T2D), sensitized lung cancer cells bearing wild-type EGFR to Erlo treatment by enriching cancer cells expressing higher levels of EGFR with persistent phosphorylation. | 29312591 | 2017 | ||||
|
0.370 | Biomarker | disease | CTD_human | EGF receptor (ERBB1) abundance in adipose tissue is reduced in insulin-resistant and type 2 diabetic women. | 22238402 | 2012 | ||||
|
0.370 | Biomarker | disease | BEFREE | In this review, we discuss the link between the EGFR transactivation and microvascular dysfunction that occurs in type 2 diabetes. | 19943320 | 2010 |